Cutaneous Chronic Graft-Versus-Host Disease: Clinical Manifestations, Diagnosis, Management, and Supportive Care.

Cutaneous chronic graft-versus-host disease (cGVHD) is associated with morbidity, mortality, and impaired quality of life after hematopoietic stem cell transplantation. The clinical features of cutaneous cGVHD are heterogeneous but can be broadly classified into nonsclerotic or sclerotic presentations. This review provides an overview of clinical presentation, diagnosis and differential diagnosis, grading, and treatment of cutaneous cGVHD. Particular attention is given to cutaneous cGVHD in skin of color, which can have unique features and is generally underrepresented in the literature leading to delays in diagnosis. Finally, an overview of long-term skin care for patients with cutaneous cGVHD is provided in order to support patients from a dermatologic perspective as they recover from cGVHD. Multidisciplinary care with frequent communication between transplant specialists and dermatologists is critical to effectively managing cutaneous cGVHD.

Informations de copyright

Copyright © 2024 The American Society for Transplantation and Cellular Therapy. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest Statement CRS: Editorial: VisualDX. HKC: Research: Opna. Consulting: Incyte, Sanofi, Abbvie, Actinium. BHK: Research: Biogen, Merck, InflaRx, BMS, Dermatology Foundation, National Psoriasis Foundation. Consulting: Novartis, Novocure, ADC Therapeutics, Elsevier.